Skip to content

Prospective Randomized Comparison of Conservative and Opertaive Treatment of Radius Fractures in Elderly Patients

Prospective Randomized Comparison of Conservative and Opertaive Treatment of Radius Fractures in Elderly Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04655768
Enrollment
80
Registered
2020-12-07
Start date
2020-11-01
Completion date
2024-12-31
Last updated
2022-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopedic Disorder

Keywords

radius fracture, clinical outcome

Brief summary

Elderly Patients often suffer from radius fracture. Treatment options are conservative and operative. Aim of the stdy is to find out if there are diffrences in Patient's satisfaction depending on the different treatment. A randomized prospective trial is palnned

Detailed description

Patients of 70 years and more of age who suffer from C1 or C2 radius fracture are randomized treated by conservative treatment and operative treatment. Primary aim is PRWE, secondary ROM as well as power and DASH score.

Interventions

DEVICEPalmar Plate Fixation

Patients are treated by surgery (palmar plate)

Sponsors

Kepler University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Radius Fractures C1-C2 * age over 70

Exclusion criteria

* demetia * collateral damages * age \< 70

Design outcomes

Primary

MeasureTime frameDescription
Patient Related Wrist Evaulation12-24 months post interventionPRWE, ROM investigation

Secondary

MeasureTime frameDescription
ROM12-24 months post interventionPRWE, ROM, Investigation

Countries

Austria

Contacts

Primary ContactStefan M Froschauer, MD
stefan.froschauer@kepleruniklinikum.at+4373278061020

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026